Show Summary Details
Page of

Undertreatment of pain with metastatic cancer 

Undertreatment of pain with metastatic cancer
Undertreatment of pain with metastatic cancer

Matthew J. Allsop

, and Michael Bennett

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 September 2021

The landmark paper discussed in this chapter is ‘Pain and its treatment in outpatients with metastatic cancer’, published by Cleeland et al. in 1994. Cleeland and colleagues provide one of the first epidemiological studies outlining the prevalence of cancer pain in outpatients with metastatic cancer. The study drew attention to the undertreatment of pain and identified predictors of poor pain management, such as discrepancies between patient and health professional judgements regarding the degree of pain-induced interference. Issues highlighted by Cleeland and colleagues persist, including high prevalence of pain reported in patients with metastatic cancer, a lack of clarity on good practice guidelines for assessing pain in patients with cancer, and substandard quality of palliative and end-of-life services by minority ethnic groups. Pain management in outpatients with cancer remains a complex issue, but innovative strategies are emerging to support the role of the health professional and encouraging self-management in patients.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.